According to Botanix Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.006140. In 2024 the company made an earnings per share (EPS) of -$0.006140 a decrease over its 2023 EPS that were of -$0.005265.
Year | EPS | Change |
---|---|---|
2024 | -$0.006140 | 16.63% |
2023 | -$0.005265 | -43.46% |
2022 | -$0.009312 | 265.28% |
2021 | -$0.002549 | -79.37% |
2020 | -$0.01235 | -21.47% |
2019 | -$0.01573 | -5.97% |
2018 | -$0.01673 | 98.11% |
2017 | -$0.008445 | 4.98% |
2016 | -$0.008045 | -10.64% |
2015 | -$0.009002 | -65.03% |
2014 | -$0.02574 | -93.52% |
2013 | -$0.40 | -73.89% |
2012 | -$1.52 | -37.35% |
2011 | -$2.43 | -9.01% |
2010 | -$2.67 | -38.06% |
2009 | -$4.31 | -16.82% |
2008 | -$5.18 | -16.27% |
2007 | -$6.19 | 24.16% |
2006 | -$4.98 | -93.26% |
2005 | -$73.87 | 277.68% |
2004 | -$19.56 | -35.18% |
2003 | -$30.17 | 21.06% |
2002 | -$24.92 | 329.48% |
2001 | -$5.80 | -91.46% |
2000 | -$67.94 | -66.48% |
1999 | -$202.66 | -52.27% |
1998 | -$424.63 | 4.15% |
1997 | -$407.70 | -365.92% |
1996 | $153.32 |